Caxton Associates (New York)’s Hologic HOLX Stock Holding History

Caxton Associates (New York)’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-17,163	Closed	-$1.19M	–	498
2023 Q3	$1.19M	Sell	17,163 -5,973	-26%	-$451K	0.16%	117
2023 Q2	$1.87M	Buy	23,136 +16,346	+241%	+$1.34M	0.28%	73
2023 Q1	$548K	Sell	6,790 -4,070	-37%	-$328K	0.08%	240
2022 Q4	$812K	Buy	10,860 +2,601	+31%	+$185K	0.05%	150
2022 Q3	$533K	Sell	8,259 -4,417	-35%	-$306K	0.07%	224
2022 Q2	$878K	Buy	+12,676	New	+$941K	0.09%	149
2020 Q4	–	Sell	-7,261	Closed	-$483K	–	226
2020 Q3	$483K	Buy	+7,261	New	+$460K	0.05%	118
2019 Q3	–	Sell	-5,883	Closed	-$283K	–	457
2019 Q2	$283K	Buy	+5,883	New	+$272K	0.03%	298
2018 Q4	–	Sell	-8,594	Closed	-$352K	–	369
2018 Q3	$352K	Buy	8,594 +2,668	+45%	+$108K	0.02%	296
2018 Q2	$236K	Sell	5,926 -12,805	-68%	-$493K	0.01%	338
2018 Q1	$700K	Buy	+18,731	New	+$757K	0.04%	229
2017 Q3	–	Sell	-13,100	Closed	-$594K	–	545
2017 Q2	$594K	Buy	+13,100	New	+$578K	0.02%	270

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Caxton Associates (New York)'s HOLX Position: Q4 2023 in Review

Caxton Associates (New York) sold out of Hologic (HOLX) in Q4 2023, closing a stake of 17,163 shares — an estimated $1.19M sold.

Caxton Associates (New York) first reported a position in HOLX in Q2 2017 and held it in 12 quarters. The position peaked at $1.87M in Q2 2023. 733 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

Caxton Associates (New York) reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
Caxton Associates (New York) sold 17,163 Hologic shares in Q4 2023, an estimated $1.19M.
Caxton Associates (New York) first reported a position in Hologic in Q2 2017 and held it in 12 quarters.
Caxton Associates (New York)'s Hologic position peaked at $1.87M in Q2 2023.
733 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on Caxton Associates (New York)'s 13F filing for Q4 2023, filed 14 Feb 2024.